Switching treatments in COPD: implications for costs and treatment adherence

Inhaled therapy is key to the management of chronic obstructive pulmonary disease (COPD). New drugs and inhalers have recently been launched or will soon become available, and the expiry of patent protection covering several currently used inhaled bronchodilators and corticosteroids will be accompan...

Descripción completa

Detalles Bibliográficos
Autores principales: Braido, Fulvio, Lavorini, Federico, Blasi, Francesco, Baiardini, Ilaria, Canonica, Giorgio Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671757/
https://www.ncbi.nlm.nih.gov/pubmed/26664108
http://dx.doi.org/10.2147/COPD.S79635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671757/
https://www.ncbi.nlm.nih.gov/pubmed/26664108
http://dx.doi.org/10.2147/COPD.S79635

Ejemplares similares